The current investigation demonstrates that PCA3 and CBR3-AS1 may play a carcinogenic role in individuals with GC since tumor tissue showed higher levels of PCA3 and CBR3-AS1 expression than marginal tissues. This evidence concerns the gene CBR3 and gastric cancer.